Bio Path | BPTH - Koszty Operacyjne





Koszty Operacyjne Zmiana Data
Alterity Therapeutics Limited AUD 8.67M 893.38K 2025-12
Baxter International USD 2.68B 3.36B 2026-06
Bio Path USD 297K 191K 2026-03
Cipla INR 62.31B 3.04B 2026-06
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 11.19M 96K 2026-03
CSL USD 5.7B 2.82B 2025-12
Grifols EUR 1.99B 217.4M 2025-12
Karyopharm Therapeutics USD 61.83M 9.9M 2026-03